Our company became the founding member of Nanjing Biomedical Science and Technology Industry Innovation Investment Promotion Association
2019-12-30
On December 29, led by the Nanjing Investment Promotion Bureau, with the participation of more than 300 people in the fields of "politics, industry, academia, research, medicine, and capital", the Nanjing Biomedical Industry Innovation Investment Promotion Association (hereinafter referred to as the "Drug Promotion Association") The first council was held and the leadership of the "Drug Promotion Association" was elected. This is the city's first investment promotion association in the field of landmark industries, and it is also an attempt by Nanjing to fully integrate various elements of the biomedical industry, attract business with business, and attract investment in industrial ecology.
On December 29, led by the Nanjing Investment Promotion Bureau, with the participation of more than 300 people in the fields of "politics, industry, academia, research, medicine, and capital", the Nanjing Biomedical Industry Innovation Investment Promotion Association (hereinafter referred to as the "Drug Promotion Association") The first council was held and the leadership of the "Drug Promotion Association" was elected. This is the city's first investment promotion association in the field of landmark industries, and it is also an attempt by Nanjing to fully integrate various elements of the biomedical industry, attract business with business, and attract investment in industrial ecology.
Why did Nanjing rush to set up the "Drug Promotion Association" at the end of 2019 "? To this end, the person in charge of the Nanjing Investment Promotion Bureau gave the answer at the scene," In order to comprehensively promote the high-quality development of Nanjing, in accordance with the decision and deployment of the Municipal Party Committee and the Municipal Government to build a '4 4 1 'leading industrial system, Nanjing is actively biomedicine. The industry serves as a new engine for high-quality economic development, gathers industrial resources and innovative elements, builds a 100 billion-level industrial cluster, and creates the province's first and 3. globally influential industrial landmark, to build Nanjing into a world-renowned biomedical innovation center, a unique genetic technology and cell therapy industry highland.
Nanjing, as one of the cities with the largest number of biomedical education institutions in the country, has the advantage of biomedical talents in the country. But at the same time, the development of the biomedical industry also has the problems of small industrial scale and low capital activity." In order to effectively promote the high-quality development of the city's biomedical industry, the Nanjing Investment Promotion Bureau promoted the establishment of the Nanjing Biomedical Industry Innovation Investment Promotion Association. At the inaugural meeting that day, Ren Jinsheng, chairman of Jiangsu Simcere Pharmaceutical Co., Ltd., was elected as the first rotating president of the "Drug Promotion Association. Shen Hongbing, Wang Xuehao, Fan Daiming, Wang Guangji and other domestic college-level experts have also been employed as consultants of the "Drug Promotion Association. The "Drug Promotion Association" has a total of 213 member units in the first batch, and is the only investment promotion association in the province aimed at the agglomeration and development of innovative elements in a single industrial chain.
Our company has become a founding member of Nanjing Biomedical Science and Technology Industry Innovation and Investment Promotion Association.
Related News
Nanjing Pratt Biotechnology Co., Ltd.
-
Address: 3rd Floor, Building 6, 123 Houjiao Road, Jiangning District, Nanjing
Telephone: 025-52715975
+86 17749585716Mailbox: lzb@predicte.cn
Contact: Mr. Liu Zhibin
Copyright 2024 Nanjing Purite Biotechnology Co., Ltd. All Rights Reserved